2026 MIDD Webinar Series | Beyond the Simulation: Embedding MIDD into Strategic Drug Development
Includes a Live Web Event on 06/24/2026 at 12:00 PM (EDT)
-
Register
- Non-member - $50
- Member - Free!
This talk explores how model-informed drug development (MIDD) can evolve from a supportive tool into a central pillar of clinical strategy. Using the development of AZD8233—a novel PCSK9 antisense oligonucleotide—as a case study, the presentation will walk through how modeling guided key decisions from Phase 2b to Phase 3, including trial design, dose optimization, and cardiovascular risk prediction.
The MIDD Webinar Series, coordinated by Yash Kapoor and Fulya Akpinar Singh, is a series of webinars focused on shaping the future of drug development and regulatory decision-making sponsored by the ISoP Education Committee. Topics range from MIDD approaches in regulatory submission to pharmacometrics topics that are at the core of model development.
Gina Song
Gina Song is a Director in the Oncology Global Clinical Development organization, Quantitative Pharmacology and Pharmacometrics (QP2) function at Merck. She has over 10 years of experiences in the Pharmaceutical industry across therapeutic areas including preclinical and clinical oncology, infectious disease and pediatric development for different modalities with time spent at Hamner Institute, Labcorp and currently Merck. She is currently leading SC pembrolizumab program for clinical pharmacology and modeling &simulation efforts across indications as well as supporting regulatory submissions in global markets.
Key:
Complete
Next
Failed
Available
Locked